<code id='25E0092726'></code><style id='25E0092726'></style>
    • <acronym id='25E0092726'></acronym>
      <center id='25E0092726'><center id='25E0092726'><tfoot id='25E0092726'></tfoot></center><abbr id='25E0092726'><dir id='25E0092726'><tfoot id='25E0092726'></tfoot><noframes id='25E0092726'>

    • <optgroup id='25E0092726'><strike id='25E0092726'><sup id='25E0092726'></sup></strike><code id='25E0092726'></code></optgroup>
        1. <b id='25E0092726'><label id='25E0092726'><select id='25E0092726'><dt id='25E0092726'><span id='25E0092726'></span></dt></select></label></b><u id='25E0092726'></u>
          <i id='25E0092726'><strike id='25E0092726'><tt id='25E0092726'><pre id='25E0092726'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:83157
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Readout LOUD podcast: 2023 in review, and a look at biotech in 2024
          Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

          WhatdoesitmeantoabadCEO?Canbiotechendureanotherelectionyear?AndcanyougototoomanyJ.P.Morganparties?We

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Three issues to watch in global health in 2024

          ChristineKao/STATAsweenterthefifthyearofthischallengingdecade,lifefinallyappearstobeinchingtowardnor